Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. MSTR
4. BAUFF
5. ICE
6. ABBV
7. DFTX
8. BTGO
9. FCLI
10. CART

Go back to Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.13 --0 (-0%)
Previous Close $9.13    52 Week High $9.23 
Open $9.13    52 Week Low $1.16 
Day High $9.13    P/E N/A 
Day Low $9.13    EPS $-0.30 
Volume 18,604